heme101
良性疾病 › 貧血

鐵芽球性貧血

Sideroblastic Anemia
良性疾病 未策展 更新 2026-08-02

概覽

Buzzwords → Dx

Buzzword Diagnosis / Clue
Ringed sideroblasts on Prussian blue stain Diagnostic
Microcytic-to-macrocytic dimorphic anemia Sideroblastic gestalt
High serum iron + high ferritin + high TSAT (vs IDA pattern) Iron overload despite anemia
X-linked ALAS2 mutation Hereditary; B6 (pyridoxine) responsive
SF3B1 mutation + ringed sideroblasts MDS-SF3B1 (or MDS-RS); favorable prognosis MDS
Lead poisoning + basophilic stippling Acquired sideroblastic + neuropathy
Isoniazid use without B6 Reversible sideroblastic
Alcoholism / chronic Sideroblastic with B6 antagonism
Copper deficiency (zinc excess, gastric bypass, parenteral nutrition) Sideroblastic with neutropenia + ataxia + myelopathy
Chloramphenicol Reversible sideroblastic

分類與診斷

Diagnostic Criteria

  • Ringed sideroblasts ≥15 % of erythroblasts on Prussian blue iron stain (or ≥5 % with SF3B1 mutation = MDS-RS per WHO 5e).
  • Iron studies: elevated serum iron, ferritin, TSAT (vs IDA which has low values).
  • Marrow biopsy + cytogenetics + NGS to subtype.
  • Genetic testing for hereditary (ALAS2, SLC25A38, GLRX5, ATP12, TRNT1, ABCB7).
  • Lead level if exposure suspected (children with pica, occupational, water sources).
  • Drug review (INH, alcohol, chloramphenicol).
  • Copper, ceruloplasmin if neuropathy + neutropenia.

Workup

  • CBC + smear + retic (basophilic stippling in lead).
  • Iron studies (Fe, TIBC, ferritin, TSAT).
  • B12, folate, B6 (pyridoxine).
  • Lead level.
  • Marrow biopsy with Prussian blue stain + karyotype + NGS panel (SF3B1, others).
  • Copper + ceruloplasmin if non-clonal sideroblastic suspected.
  • Drug history + alcohol use review.

治療

Treatment Algorithm

flowchart TD
  A[Sideroblastic anemia confirmed] --> B{Cause}
  B -- hereditary X-linked ALAS2 --> C[Pyridoxine 50-200 mg/d trial<br>often dramatic response]
  B -- MDS-RS / SF3B1 mutation --> D[Luspatercept first-line<br>COMMANDS trial<br>or HMA in higher-risk MDS]
  B -- lead poisoning --> E[Remove exposure + chelation<br>EDTA / DMSA / dimercaprol]
  B -- isoniazid / alcohol / chloramphenicol / drug --> F[Discontinue / replace<br>+ pyridoxine]
  B -- copper deficiency --> G[Copper repletion<br>oral or parenteral; remove zinc excess]
  C --> H[Iron overload monitoring<br>chelation if ferritin >1000 or LIC high]
  D --> H
  H --> I[Deferasirox / deferoxamine / deferiprone<br>per iron loading]

陷阱與考點

Pearls / Pitfalls

  • High iron + high ferritin + low Hb = sideroblastic, not IDA. Don't give iron — worsens overload.
  • Hereditary X-linked sideroblastic anemia can dramatically respond to pyridoxine (B6) — always trial in suspected hereditary cases.
  • MDS-SF3B1 (MDS-RS) has favorable prognosis among MDS — treat with luspatercept (COMMANDS) or watch.
  • Lead poisoning: classical microcytic with basophilic stippling, abdominal pain, peripheral neuropathy (wrist drop), behavioral/cognitive. Pediatric pica + water/paint exposure.
  • Isoniazid (INH) depletes B6 → sideroblastic + peripheral neuropathy. Always co-prescribe pyridoxine 25–50 mg/d with INH.
  • Copper deficiency (post-gastric bypass, zinc-rich denture cream, parenteral nutrition without copper) → sideroblastic + neutropenia + ataxia + myelopathy. Replete copper.
  • Iron overload is universal in chronic sideroblastic — iron chelation when ferritin >1000 or hepatic iron concentration high. Avoid additional iron supplements.
  • Alcohol chronic — multifactorial (sideroblastic + folate deficiency + direct toxicity) — abstinence + nutrition.
  • Chloramphenicol — reversible sideroblastic with high doses; rarely used now.

延伸

Cross-references

相關題目

  • Q-121 — Sideroblastic anemia — pyridoxine response
  • Q-122 — Sideroblastic anemia — copper deficiency mimic
  • Q-123 — Sideroblastic anemia — lead poisoning

來源

Sources

Footnotes

  1. Bottomley SS, Fleming MD. Sideroblastic Anemia: Diagnosis and Management. Hematology/Oncology Clinics of North America 2014;28(4):653–670. doi:10.1016/j.hoc.2014.04.008.